Print Page

藥 物 回 收

 
Singapore: Recall of two batches of Minirin Nasal Spray (desmopressin) 0.1mg/ml (2.5ml) (English only)
 
The Health Sciences Authority (HSA) announces that Ferring Pharmaceuticals Pte Ltd is recalling 2 batches of Minirin Nasal Spray (desmopressin) 0.1mg/ml (2.5ml) (batch number: R14347H, R14347L) to the consumer level because out-of-specification results where higher concentrations of the active substance, desmopressin, have been detected in the affected batches during testing. The affected batches are being recalled by the company.

Please refer to the following website in HSA for details:http://www.hsa.gov.sg/announcements/product-recall/recall-of-two-batches-of-minirin-nasal-spray-(desmopressin)-0.1mg-ml-(2.5ml)

In Hong Kong, Minirin Nasal Spray 0.1mg/ml (HK-30498) is a pharmaceutical product registered by Ferring Pharmaceuticals Ltd (Ferring), and is a prescription-only medicine. As confirmed with Ferring, the above product is currently not marketed in Hong Kong. Related news was previously issued by HSA, and was posted on the Drug Office website on 15 Jul 2020.

Ends/ Saturday, 25 Jul, 2020
Issued at HKT 13:00
 
Related Information:
The United States: Ferring US issues voluntary nationwide recall of DDAVP® Nasal... 上載於 2020-08-07
台灣:回收迷你寧鼻腔噴霧劑10 UG/DOSE MINIRIN NASAL SPRAY 10 UG/DOSE 上載於 2020-07-28
Canada: Three lots of antidiuretic DDAVP Spray recalled because of potential ove... 上載於 2020-07-17
The United Kingdom: Class 2 Medicines Recall: Ferring Pharmaceuticals Limited, d... 上載於 2020-07-16
Singapore: Recall of Minirin Nasal Spray (desmopressin) 0.1mg/ml (2.5ml) (Engli... 上載於 2020-07-15
 
back